Simioni Julia, Hutton Eileen K, Gunn Elizabeth, Holloway Alison C, Stearns Jennifer C, McDonald Helen, Mousseau Andrea, Schertzer Jonathan D, Ratcliffe Elyanne M, Thabane Lehana, Surette Michael G, Morrison Katherine M
Midwifery Education Program, McMaster University, Hamilton, ON, Canada.
Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON, Canada.
BMC Pediatr. 2016 Nov 10;16(1):183. doi: 10.1186/s12887-016-0724-5.
The intestinal microbiota influences metabolic, nutritional, and immunologic processes and has been associated with a broad range of adverse health outcomes including asthma, obesity and Type 2 diabetes. Early life exposures may alter the course of gut microbial colonization leading to differences in metabolic and immune regulation throughout life. Although approximately 50 % of low-risk full-term infants born in Canada are exposed to intrapartum antibiotics, little is known about the influence of this common prophylactic treatment on the developing neonatal intestinal microbiota. The purpose of this study is to describe the intestinal microbiome over the first 3 years of life among healthy, breastfed infants born to women with low-risk pregnancies at full term gestation and to determine if at 1 year of age, the intestinal microbiome of infants exposed to intrapartum antibiotics differs in type and quantity from the infants that are not exposed.
A prospectively followed cohort of 240 mother-infant pairs will be formed by enrolling eligible pregnant women from midwifery practices in the City of Hamilton and surrounding area in Ontario, Canada. Participants will be followed until the age of 3 years. Women are eligible to participate in the study if they are considered to be low-risk, planning a vaginal birth and able to communicate in English. Women are excluded if they have a multiple pregnancy or a preterm birth. Study questionnaires are completed, anthropometric measures are taken and biological samples are acquired including eight infant stool samples between 3 days and 3 years of age.
Our experience to date indicates that midwifery practices and clients are keen to participate in this research. The midwifery client population is likely to have high rates of breastfeeding and low rates of intervention, allowing us to examine the comparative development of the microbiome in a relatively healthy and homogenous population. Results from this study will make an important contribution to the growing understanding of the patterns of intestinal microbiome colonization in the early years of life and may have implications for best practices to support the establishment of the microbiome at birth.
肠道微生物群会影响代谢、营养和免疫过程,并与包括哮喘、肥胖和2型糖尿病在内的一系列不良健康结果相关。生命早期的暴露可能会改变肠道微生物定植的进程,导致一生当中代谢和免疫调节方面的差异。尽管在加拿大出生的约50%低风险足月婴儿会在分娩期接触抗生素,但对于这种常见预防性治疗对新生儿肠道微生物群发育的影响却知之甚少。本研究的目的是描述足月妊娠低风险孕妇所生健康、母乳喂养婴儿在生命最初3年的肠道微生物组,并确定1岁时,接触分娩期抗生素的婴儿的肠道微生物组在类型和数量上是否与未接触的婴儿不同。
通过招募加拿大安大略省汉密尔顿市及周边地区助产机构符合条件的孕妇,组建一个前瞻性随访队列,包含240对母婴。参与者将被随访至3岁。如果女性被认为是低风险、计划顺产且能用英语交流,则有资格参与本研究。如果有多胎妊娠或早产则被排除。完成研究问卷,进行人体测量并采集生物样本,包括3天至3岁期间的8份婴儿粪便样本。
我们目前的经验表明,助产机构和客户都热衷于参与这项研究。助产机构的客户群体可能母乳喂养率高且干预率低,这使我们能够在相对健康和同质的人群中研究微生物组的比较发育情况。本研究结果将为增进对生命早期肠道微生物组定植模式的理解做出重要贡献,并可能对支持出生时微生物组建立的最佳实践产生影响。